R.Pen by Subhaa Group is a clinic-grade, wireless microneedling device with LED-BioLights, offering customizable speed, depth, and cartridge options for professional mesotherapy and skin rejuvenation in India.
R.Pen – Wireless Microneedle Mesotherapy Device with LED-Derma BioLights
R.PEN by Subhaa Group is a cutting-edge wireless microneedling device designed for advanced mesotherapy and clinical skin rejuvenation. Engineered for flexibility and professional precision, it features five adjustable speed levels, customizable needle depth, and the LED-Derma BioLights system to enhance therapy results.
Key Benefits
• Wireless design for maximum versatility and maneuverability in medical practice
• LED-Derma BioLights deliver targeted light therapy for amplified treatment outcomes
• Five adjustable speeds and customizable insertion depth for patient-tailored procedures
• Certified and trusted for clinical dermatology and aesthetic medicine
Professional Indications
• Skin rejuvenation and revitalization
• Wrinkle and fine line reduction
• Stretch mark, acne scar, and post-inflammatory change treatment
• Enhanced delivery of active ingredients with precision and safety
Cartridge Options
• 12-Needle Cartridge: Ideal for acne, firmness, and nourishment protocols (e.g., RETIBOOSTER, MESOLAB)
• 36-Needle Cartridge: Deeper rejuvenation, wrinkle/scar reduction (e.g., SMART DNA THERAPY)
• Nanoneedle Cartridge: Gentle delivery of actives, suitable for sensitive or comfort-focused therapies
Frequently Asked Questions (FAQ)
What is R.Pen?
A wireless, LED-equipped professional microneedling device for mesotherapy and advanced aesthetic skin therapies.
Who should use R.Pen?
Certified dermatology and aesthetic professionals aiming for advanced precision in facial and body rejuvenation.
Where is R.Pen available?
Exclusively through Subhaa Group, serving clinics and professionals across India.
We’re proud to be one of India’s most trusted
distributors of premium dermatology and
aesthetic medicine products.
Reviews
There are no reviews yet.